Designing randomised trials: Both large and small trials are needed

Annals of Oncology

Volumn 13, Issue SUPPL. 4, 2002, Pages 131-138

  Stenning, S P ^a   Parmar, M K B ^a  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL;

ADULT; ARTICLE; CANCER RECURRENCE; CANCER RESEARCH; CANCER STAGING; CANCER SURVIVAL; CLINICAL RESEARCH; CLINICAL STUDY; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; MALE; METHODOLOGY; ORCHIECTOMY; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SAMPLING; SEMINOMA; SIDE EFFECT;

EID: 0036435887     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdf650     Document Type: Article

References (14)

1. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. International Multicentre Pooled Analysis of Colon Cancer Traits (IMPACT) investigators. Lancet 1995; 345: 939-944.
2. Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Lancet 1998; 352: 930-942.
3. Prentice RL. Surrogate endpoints in clinical trials: definition and operational criteria. Stat Med 1989; 8: 431-440.
4. Buyse M, Thirion P, Carlson RW et al. Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysis. Lancet 2000; 356: 373-378.
5. Fleming TR. Surrogate markers in AIDS and cancer trials. Stat Med 1994; 13: 1423-1435.
6. Karim ABMF, Afra D, Cornu P et al. A randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: EORTC study 22845 with MRC study BR04: an interim analysis. Int J Rad Oncol Biol Phys 2002; 52: 316-324.
7. Tierney JF, Stewart LA, Parmar MK et al. Adjuvant chemotherapy for localised soft-tissue sarcoma of adults; meta-analysis of individual data. Lancet 1997; 350: 1647-1654.
8. Schwartz F, Lellouch A. Explanatory and pragmatic attitudes in therapeutic trials. J Chron Dis 1967; 20: 637-648.
9. Freedman LS, Spiegelhalter DJ. The assessment of subjective opinion and its use in relation to stopping rules for clinical trials. Statistician 1983; 32: 153-160.
10. Saunders M, Dische S, Barrett A et al. Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: A randomized multicentre trial. Lancet 1997; 350: 161-165.
11. Parmar MKB, Griffiths GO, Spiegelhalter DJ et al. Monitoring of large randomized clinical trials: a new approach with Bayesian methods. Lancet 2001; 358: 375-381.
12. Jones WG, Fossa SD, Mead GM et al. A randomized trial of two radiotherapy schedules in the adjuvant treatment of stage I seminoma (MRC TE18). Eur J Cancer 2001; 37 (Suppl. 6): S157 (Abstr 572).
13. Gray R, James R, Mossman J, Stenning SP. AXIS: a suitable case for treatment (Guest editorial). Br J Cancer 1991; 63: 841-845.
14. Girling DJ, Parmar MKB, Stenning SP et al. Cancer Clinical Trials: Principles and Practice. Oxford: Oxford University Press 2002.